Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of down syndrome

Neural Plasticity

Volumn 2012, Issue , 2012, Pages

  Heinen, Markus ^a   Hettich, Moritz M ^a   Ryan, DeVon P ^a   Schnell, Susanne ^a   Paesler, Katharina ^a   Ehninger, Dan ^a  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN SYNDROME; GABAERGIC TRANSMISSION; GENE INTERACTION; GENOTYPE; HIPPOCAMPUS; LEARNING; MEMORY DISORDER; MORTALITY; MOUSE; MOUSE STRAIN; NERVE CELL PLASTICITY; NONHUMAN; OUTCOME ASSESSMENT; SEIZURE; ANIMAL; ANIMAL BEHAVIOR; BODY WEIGHT; C3H MOUSE; C57BL MOUSE; CELL COUNT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; GENETICS; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MOTOR ACTIVITY; PSYCHOLOGICAL ASPECT;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CELL COUNT; COGNITION DISORDERS; DOWN SYNDROME; FEMALE; FLUOXETINE; GABA-A RECEPTOR ANTAGONISTS; GENOTYPE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MOTOR ACTIVITY; SEIZURES; SEROTONIN UPTAKE INHIBITORS;

EID: 84864910192     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2012/467251     Document Type: Article

References (42)

1. Escorihuela R. M., Fernandez-Teruel A., Vallina I. F., Baamonde C., Lumbreras M. A., Dierssen M., Tobena A., Florez J., A behavioral assessment of Ts65Dn mice: a putative Down syndrome model Neuroscience Letters 1995 199 2 143 146
2. Reeves R. H., Irving N. G., Moran T. H., Wohn A., Kitt C., Sisodia S. S., Schmidt C., Bronson R. T., Davisson M. T., A mouse model for Down syndrome exhibits learning and behaviour Deficits Nature Genetics 1995 11 2 177 184
3. Belichenko P. V., Kleschevnikov A. M., Masliah E., Wu C., Takimoto-Kimura R., Salehi A., Mobley W. C., Excitatory-inhibitory relationship in the fascia Dentata in the Ts65Dn mouse model of Down syndrome Journal of Comparative Neurology 2009 512 4 453 466
4. Fernandez F., Morishita W., Zuniga E., Nguyen J., Blank M., Malenka R. C., Garner C. C., Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome Nature Neuroscience 2007 10 4 411 413 (Pubitemid 46494581)
5. Kleschevnikov A. M., Belichenko P. V., Gall J., George L., Nosheny R., Maloney M. T., Salehi A., Mobley W. C., Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome Neurobiology of Disease 2012 45 2 683 691
6. Kleschevnicov A. M., Belichenko P. V., Villar A. J., Epstein C. J., Malenka R. C., Mobley W. C., Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome Journal of Neuroscience 2004 24 37 8153 8160 (Pubitemid 39280835)
7. Kurt M. A., Davies D. C., Kidd M., Dierssen M., Florez J., Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice Brain Research 2000 858 1 191 197 (Pubitemid 30105799)
8. Rueda N., Florez J., Martinez-Cue C., Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome Neuroscience Letters 2008 433 1 22 27
9. Hensch T. K., Critical period plasticity in local cortical circuits Nature Reviews Neuroscience 2005 6 11 877 888 (Pubitemid 41568729)
10. Hensch T. K., Fagiolini M., Mataga N., Stryker M. P., Baekkeskov S., Kash S. F., Local GABA circuit control of experience-depenDent plasticity in Developing visual cortex Science 1998 282 5393 1504 1508 (Pubitemid 28538615)
11. Vetencourt J. F. M., Sale A., Viegi A., Baroncelli L., De Pasquale R., O'Leary O. F., Castren E., Maffei L., The antidepressant fluoxetine restores plasticity in the adult visual cortex Science 2008 320 5874 385 388 (Pubitemid 351555663)
12. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J. W., Maffei L., Reactivation of ocular dominance plasticity in the adult visual cortex Science 2002 298 5596 1248 1251 (Pubitemid 35285495)
13. Sale A., Maya Vetencourt J. F., Medini P., Cenni M. C., Baroncelli L., De Pasquale R., Maffei L., Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition Nature Neuroscience 2007 10 6 679 681 (Pubitemid 46828505)
14. Spolidoro M., Sale A., Berardi N., Maffei L., Plasticity in the adult brain: lessons from the visual system Experimental Brain Research 2009 192 3 335 341
15. Ehninger D., Li W., Fox K., Stryker M. P., Silva A. J., Reversing neuroDevelopmental disorDers in adults Neuron 2008 60 6 950 960
16. Bianchi P., Ciani E., Contestabile A., Guidi S., Bartesaghi R., Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down syndrome Brain Pathology 2010 20 1 106 118
17. Braudeau J., Dauphinot L., Duchon A., Chronic treatment with a promnesiant GABA-A alpha5-selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a Down syndrome mouse model AdVances in Pharmacological Sciences 2011 2011 11
18. Braudeau J., Delatour B., Duchon A., Specific targeting of the GABA-A receptor alpha5 subtype by a selective inverse agonist restores cognitive Deficits in Down syndrome mice Journal of Psychopharmacology 2011 25 8 1030 1042
19. Mazur-Kolecka B., Golabek A., Kida E., Rabe A., Hwang Y.-W., Adayev T., Wegiel J., Flory M., Kaczmarski W., Marchi E., Frackowiak J., Effect of DYRK1A activity inhibition on Development of neuronal progenitors isolated from Ts65Dn mice Journal of Neuroscience Research 2012 90 5 999 1010
20. Choi H. C., Kim Y. I., Song H. K., Kim J. E., Kim D. S., Kang T. C., Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats Brain Research 2010 1357 C 131 141
21. Feng J., Cai X., Zhao J., Yan Z., Serotonin receptors modulate GABA A receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons Journal of Neuroscience 2001 21 17 6502 6511 (Pubitemid 32781094)
22. Gulyas A. I., Acsady L., Freund T. F., Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus Neurochemistry International 1999 34 5 359 372 (Pubitemid 29240632)
23. Zhong P., Yan Z., Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons Neuroscience 2004 129 1 65 73 (Pubitemid 39360942)
24. Granholm A. C. E., SanDers L. A., Crnic L. S., Loss of cholinergic phenotype in basal forebrain coincides with cognitive Decline in a mouse model of Down's syndrome Experimental Neurology 2000 161 2 647 663 (Pubitemid 30137022)
25. West M. J., Slomianka L., GunDersen H. J., Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator The Anatomical Record 1991 231 4 482 497
26. Paxinos G., The Mouse Brain in Stereotaxic Coordinates 2003 3rd New York, NY, USA Academic Press
27. Holtzman D. M., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D. J., Daniels S. E., Johnson R. M., Chen K., Sun Y., Carlson E., Alleva E., Epstein C. J., Mobley W. C., Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome Proceedings of the National Academy of Sciences of the United States of America 1996 93 23 13333 13338 (Pubitemid 26382816)
28. Lockrow J., Prakasam A., Huang P., Bimonte-Nelson H., Sambamurti K., Granholm A. C., Cholinergic degeneration and memory loss Delayed by vitamin E in a Down syndrome mouse model Experimental Neurology 2009 216 2 278 289
29. Oke A., Adhiyaman V., Aziz K., Ross A., Dose-depenDent seizure activity associated with fluoxetine therapy QJMMonthly Journal of the Association of Physicians 2001 94 2 113 114 (Pubitemid 32175538)
30. Prasher V. P., Seizures associated with fluoxetine therapy Seizure 1993 2 4 315 317
31. Rosenstein D. L., Nelson J. C., Jacobs S. C., Seizures associated with antidepressants: a review Journal of Clinical Psychiatry 1993 54 8 289 299 (Pubitemid 23273945)
32. Raju S. S., Noor A. R., Gurthu S., Giriyappanavar C. R., Acharya S. B., Low H. C., Quah S. H., Effect of fluoxetine on maximal electroshock seizures in mice: acute vs chronic administration Pharmacological Research 1999 39 6 451 454 (Pubitemid 29278398)
33. Zienowicz M., Wislowska A., Lehner M., Taracha E., Skorzewska A., Maciejak P., Plaznik A., The effect of fluoxetine in a model of chemically induced seizuresbehavioral and immunocytochemical study Neuroscience Letters 2005 373 3 226 231 (Pubitemid 41556563)
34. McVicker R. W., Shanks O. E. P., McClelland R. J., Prevalence and associated features of epilepsy in adults with Down's syndrome British Journal of Psychiatry 1994 164 528 532 (Pubitemid 24141681)
35. Stafstrom C. E., Patxot O. F., Gilmore H. E., Wisniewski K. E., Seizures in children with Down syndrome: etiology, characteristics and outcome Developmental Medicine and Child Neurology 1991 33 3 191 200
36. Westmark C. J., Westmark P. R., Malter J. S., Alzheimer's disease and down syndrome roDent models exhibit audiogenic seizures Journal of Alzheimer's Disease 2010 20 4 1009 1013
37. Karpova N. N., Pickenhagen A., Lindholm J., Tiraboschi E., Kulesskaya N., gstsdttir A., Antila H., Popova D., Akamine Y., SulliVan R., Hen R., Drew L. J., Castrén E., Fear erasure in mice requires synergy between antidepressant drugs and extinction training Science 2011 334 6063 1731 1734
38. Rantamaki T., Hendolin P., Kankaanpaa A., Mijatovic J., Piepponen P., Domenici E., Chao M. V., Mnnist P. T., Castren E., Pharmacologically diverse antidepressants rapidly activate brain-Derived neurotrophic factor receptor TrkB and induce phospholipase-C signaling pathways in mouse brain Neuropsychopharmacology 2007 32 10 2152 2162 (Pubitemid 47417694)
39. Cooper J. D., Salehi A., delcroix J. D., Howe C. L., Belichenko P. V., Chua-Couzens J., Kilbridge J. F., Carlson E. J., Epstein C. J., Mobley W. C., Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion Proceedings of the National Academy of Sciences of the United States of America 2001 98 18 10439 10444 (Pubitemid 32803038)
40. Clark S., Schwalbe J., Stasko M. R., Yarowsky P. J., Costa A. C. S., Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome Experimental Neurology 2006 200 1 256 261 (Pubitemid 44080763)
41. Malberg J. E., Eisch A. J., Nestler E. J., Duman R. S., Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus Journal of Neuroscience 2000 20 24 9104 9110 (Pubitemid 32042912)
42. Bianchi P., Ciani E., Guidi S., Trazzi S., Felice D., Grossi G., Fernandez M., Giuliani A., Calz L., Bartesaghi R., Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome Journal of Neuroscience 2010 30 26 8769 8779